The FDA assessed the safety and success of atidarsagene autotemcel dependant on facts from 37 little ones who acquired atidarsagene autotemcel in two single-arm, open up-label clinical trials As well as in an expanded accessibility plan.[seven] Youngsters who received procedure with atidarsagene aut